0Comments

PREZCOBIX Approved By FDA

Today the FDA approved Janssen Therapeutics combination HIV antiretroviral, PREZCOBIX which is a combination of darunavir 800mg and cobicistat 150mg. PREZCOBIX is indicated for the treatment of HIV-1 in combination with
by Michelle
0Comments

EVOTAZ Approved By FDA

Today the FDA approved Bristol-Myers Squibb Company’s new HIV antiretroviral combination EVOTAZ. Evotaz is a combination of atazanavir and Cobicistat and is approved for the treatment of HIV-1 infection in
by Michelle